Placebo group:Placebo

2 trials

Sponsors

Peking University School and Hospital of Stomatology, The First Hospital of Jilin University

Conditions

Adult subjects with moderate to severe plaque psoriasisoral lichen planus

Early Phase 1

Efficacy and safety of iguratimod for the treatment of erosive oral lichen planus

RecruitingChiCTR2100050748

Peking University School and Hospital of Stomatologyoral lichen planus

Start: 2021-09-16Updated: 2022-05-02

Phase 1

A phase I clinical study for pharmacokinetics, safety, tolerance and immunogenicity of QX004N in healthy volunteers: a single-center, randomized, double-blind, single-dose escalation, placebo-controlled study

RecruitingChiCTR2100051001

The First Hospital of Jilin UniversityAdult subjects with moderate to severe plaque psoriasis

Start: 2021-10-01Updated: 2022-05-16